A dose-escalation phase I study of a first-in-class cancer stemness inhibitor in patients with advanced malignancies
Langleben, Adrian, Supko, Jeffrey G., Hotte, Sebastien J., Batist, Gerald, Hirte, Hal W., Rogoff, Harry, Li, Youzhi, Li, Wei, Kerstein, David, Leggett, David, Hitron, Matthew J., Li, Chiang
Published in Journal of clinical oncology (20.05.2013)
Published in Journal of clinical oncology (20.05.2013)
Get full text
Journal Article